Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Clinician Guidelines for the Treatment of Psychiatric Disorders With Nutraceuticals and Phytoceuticals: The World Federation of Societies of Biological Psychiatry (Wfsbp) and Canadian Network for Mood and Anxiety Treatments (Canmat) Taskforce
Fereshteh Ghadiri
Fereshteh Ghadiri

Assistant Professor of Neurology

Tehran University of Medical Sciences

All Documents
1. Comparing Infusion-Related Reactions of the First Full Dose (600 Mg) Biosimilar Ocrelizumab Administration With the Standard Divided Protocol in Multiple Sclerosis Patients: A Randomized Controlled Trial Study, Acta Neurologica Belgica (2024)
2. The Impact of Social and Environmental Factors on Triggering Multiple Sclerosis Onset, Before and During the Covid-19 Pandemic: A Retrospective Study From Iran, BMC Neurology (2024)
3. Acute Attack in a Patient With Multiple Sclerosis 2 Days After Covid Vaccination: A Case Report, Acta Neurologica Belgica (2023)
4. Alternate Dosing of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Current Journal of Neurology (2023)
5. Alternate Dosing of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Current Journal of Neurology (2023)
6. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)
7. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)
8. Iranian Specialists’ Approach to Surgery in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
9. Iranian Specialists’ Approach to Surgery in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
10. Iranian Specialists’ Approach to Treatment Escalation in Multiple Sclerosis Patients With Cognitive Impairment, Current Journal of Neurology (2023)
11. Iranian Specialists’ Approach to Treatment Escalation in Multiple Sclerosis Patients With Cognitive Impairment, Current Journal of Neurology (2023)
12. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
13. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
14. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)
15. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)
16. The Correlation of Conventional and Advanced Mri Findings With Cognitive Function in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Research in Clinical Medicine (2023)
17. The Effects of Different Types of Smoking on Recovery From Attack in Hospitalized Multiple Sclerosis Patients, Clinical Neurology and Neurosurgery (2023)
18. The First Ms Attack After Methanol Toxicity in a Young Man: A Case Report, Neurological Sciences (2023)
19. Adding Erythropoietin to Intravenous Methylprednisolone in Acute Treatment of Attacks of Neuromyelitis Optica Spectrum Disorders: A Randomized Controlled Trial, Current Journal of Neurology (2022)
20. Association of Cognitive Impairment and Quality of Life in Patients With Multiple Sclerosis: A Cross-Sectional Study, Current Journal of Neurology (2022)
21. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
22. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
23. Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”, Revista da Associacao Medica Brasileira (2022)
24. Comment on “The Role of Epstein-Barr Virus in Multiple Sclerosis: From Molecular Pathophysiology to in Vivo Imaging”, Revista da Associacao Medica Brasileira (2022)
25. Covid-19 Vaccine Hesitancy in Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
26. Evaluation of Liver Injury in Multiple Sclerosis Patients Receiving Pulsed Steroid Therapy, Multiple Sclerosis and Related Disorders (2022)
27. Gut Microbiome in Multiple Sclerosis-Related Cognitive Impairment, Multiple Sclerosis and Related Disorders (2022)
28. Herpes Simplex Encephalitis After Receiving Covid-19 Vaccine; a Case Report, Frontiers in Emergency Medicine (2022)
29. Is Monkeypox a Concern in Multiple Sclerosis Patients? a Letter to Editor, Archives of Academic Emergency Medicine (2022)
30. Late-Onset Neuromyelitis Optica Spectrum Disorder: A Case Series From Iran, Revue Neurologique (2022)
31. Natalizumab-Induced Thrombocytopenia: A Case Report, Current Journal of Neurology (2022)
32. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
33. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
34. Telemedicine As a Strategic Intervention for Cognitive Rehabilitation in Ms Patients During Covid-19, Acta Neurologica Belgica (2022)
35. The Association Between Body Mass Index, Demographic and Clinical Characteristics With Cognitive Performance in Patients With Neuromyelitis Optica Spectrum Disorder, Current Journal of Neurology (2022)
36. The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients, Revista da Associacao Medica Brasileira (2022)
37. The Perspective of Iranian Patients With Multiple Sclerosis on the Third Dose of Covid-19 Vaccine, Current Journal of Neurology (2022)
38. The Role of Semantic Memory in Reducing Learning Disability in Multiple Sclerosis Patients, Clinical Schizophrenia and Related Psychoses (2022)
39. The Study of Covid-19 Infection Following Vaccination in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
40. Adverse Events Reported by Iranian Patients With Multiple Sclerosis After the First Dose of Sinopharm Bbibp-Corv, Vaccine (2021)
41. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient With Multiple Sclerosis on Dimethyl Fumarate: A Case Report, Neurological Sciences (2021)
42. Attitudes Toward Vaccination in Patients With Multiple Sclerosis: A Report From Iran, Multiple Sclerosis and Related Disorders (2021)
43. Beta-Thalassemia Intermedia With Ischemic Transients Misdiagnosed As Multiple Sclerosis: A Case Report, Current Journal of Neurology (2021)
44. Demographic Features, Behavioral Measures, and Clinical Factors As Predictors of Cognitive Function in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
45. The First Presentation of Covid-19 Two Hours After Vaccination in a Patient With Multiple Sclerosis: Can Covid Vaccine Provoke Cytokine Storm in a Patient With Asymptomatic Covid-19?, Current Journal of Neurology (2021)
46. Evaluating the Efficacy and Safety of Zytuxtm (Rituximab, Aryogen Pharmed) in Iranian Multiple Sclerosis Patients: An Observational Study, Multiple Sclerosis and Related Disorders (2019)
47. The Relationship Between Cognitive Function and Body Mass Index in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2019)